PARP has awarded Medicalgorithmics PLN 9.4 million in funding. New product to be developed based on the certified VCAST technology
Medicalgorithmics’ innovative project “Kardiobeat.CT” has been selected by the Polish Agency for Enterprise Development (PARP) for co-financing in the amount of PLN 9.4 million under the SMART Pathway initiative. The aim of this pioneering endeavor by the Polish medtech company is to develop an advanced diagnostic tool for the automatic detection and assessment of atherosclerotic plaques – a solution currently unavailable on the market. The new project will leverage the capabilities of the already commercialized, CE-certified VCAST platform. Funding disbursement for the project, with a total value of PLN 19 million, will commence following the execution of the agreement between Medicalgorithmics and PARP.